In Graves’ disease, selenium not only normalized the TSH receptor autoantibody titer but also enabled more rapid attainment of euthyroid status in patients receiving selenium supplementation and ATDs compared to those receiving ATDs alone [52, 53]. Here, TSHR is linked to Graves disease.